Butcher Arthur C 4

What Happened

• Arthur C. Butcher, EVP & Group President, MedSurg & APAC at Boston Scientific (BSX), had multiple equity transactions reported for Feb 12, 2026. He converted/exercised 2,692 derivative units into shares and received two awards totaling 50,995 restricted stock units (RSUs) (15,178 and 35,817). To satisfy tax withholding related to these transactions, 1,302 shares were withheld/disposed at $74.12 per share, totaling $96,504. The reported exercises/grants show $0.00 per-share amounts for the conversion/grants (typical for RSU settlement entries).

Key Details

• Transaction date: February 12, 2026 (all reported transactions).
• Exercise/conversion: 2,692 derivative units converted to shares (transaction code M).
• Tax withholding: 1,302 shares withheld/paid (transaction code F) at $74.12 → $96,504 withheld.
• Grants/awards: 15,178 RSUs and 35,817 RSUs granted (transaction code A), total 50,995 RSUs.
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Relevant footnotes from the filing:
  • F1: Each RSU equals one share of Boston Scientific common stock.
  • F2: Balance information reflects 401(k) plan holdings where applicable.
  • F3: One award’s shares to be issued in four equal annual installments beginning Feb 12, 2025.
  • F4: The other award’s shares to be issued in four equal annual installments beginning Feb 12, 2027.
  • F5: Option grant referenced vests in four equal annual installments beginning Feb 12, 2027.
• Filing timeliness: Not specified in the provided data.

Context

• The filing shows awards of RSUs and a conversion/exercise of derivatives rather than an open-market buy or sale. The 1,302-share disposal was a tax-withholding event (common when RSUs vest or options are exercised) — not an open-market sale reflecting a change in investment view. The RSU grants come with vesting/issuance schedules (see F3–F5), and the option referenced vests over multiple years.